stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. CDT
    stockgist
    HomeTop MoversCompaniesConcepts
    CDT logo

    CDT Equity Inc.

    CDT
    NASDAQ
    Healthcare
    Biotechnology
    Naples, FL, US6 employeesconduitpharma.com
    $3.98
    -1.12(-21.96%)

    Mkt Cap $703.8K

    $3.95
    $3210.00

    52-Week Range

    At a Glance

    AI-generated
    8-K
    CDT Equity Inc. filed a certificate of amendment to its Second Amended and Restated Certificate of Incorporation on March 24, 2026, to effect a 1-for-25 reverse stock split of its common stock, effective March 26, 2026, at 5:00 p.m. Eastern Time. Trading on a split-adjusted basis under ticker CDT is expected to begin on Nasdaq on March 27, 2026, reducing outstanding shares to approximately 4,722,450.

    $703.8K

    Market Cap

    $25M

    Revenue

    $8M

    Net Income

    Employees6
    Fundamentals

    How The Business Makes Money

    CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.

    Industry Biotechnology
    Activity

    What Changed Recently

    Material Agreement
    Feb 23, 2026

    Entry into a Material Definitive Agreement. Transactions with Investors of Sarborg Limited On February 19, 2026, CDT Equity Inc., a Delaware corporation (the “

    Material Agreement
    Jan 21, 2026

    Entry into a Material Definitive Agreement. Equity Purchase Agreement On January 16, 2026, CDT Equity Inc. (the “Company”), entered into a directed stock purcha

    Securities Modification+3 More
    Mar 24, 2026

    Material Modification to Rights of Security Holders. To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Rep

    Material Agreement+3 More
    Mar 8, 2026

    Entry into a Material Definitive Agreement. Amendment to Directed Stock Purchase Agreement As previously disclosed on January 22, 2026, CDT Equity Inc. (the “Co

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    COCHEnvoy Medical, Inc.$0.76+7.62%$16M-0.6
    LIXTLixte Biotechnology Holdi...$3.14+2.45%$14M-4.0
    ZVSAZyVersa Therapeutics, Inc...$0.24-2.76%$2M—
    ENVBEnveric Biosciences, Inc.$2.03-5.14%$1M-0.1
    NIVFNewGenIvf Group Limited$2.10-2.78%$1M0.1
    HEPAHepion Pharmaceuticals, I...$0.06-3.51%$639.1K-0.1
    CCMConcord Medical Services ...$3.91-0.26%$569.4K-0.0
    WORXSCWorx Corp.$0.12+2.95%$500.7K-0.3
    Company Profile
    CIK0001896212
    ISINUS20678X4034
    CUSIP20678X304
    Phone646 491 9132
    Address4581 Tamiami Trail North, Naples, FL, 34103, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice